Filing Details
- Accession Number:
- 0001209191-18-057797
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-08 18:04:13
- Reporting Period:
- 2018-11-07
- Accepted Time:
- 2018-11-08 18:04:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1328143 | Adamas Pharmaceuticals Inc | ADMS | Pharmaceutical Preparations (2834) | 421560076 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604541 | T Gregory Went | C/O Adamas Pharmaceuticals, Inc. 1900 Powell St., Suite 1000 Emeryville CA 94608 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-07 | 3,850 | $12.98 | 199,242 | No | 4 | P | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 182,610 | Direct |
Billionaire Hedge Funds
